221 related articles for article (PubMed ID: 8703809)
1. Positive diepoxybutane test in only one of two brothers found to be compound heterozygotes for Fanconi's anaemia complementation group C mutations.
Dokal I; Chase A; Morgan NV; Coulthard S; Hall G; Mathew CG; Roberts I
Br J Haematol; 1996 Jun; 93(4):813-6. PubMed ID: 8703809
[TBL] [Abstract][Full Text] [Related]
2. Mitomycin C and diepoxybutane action mechanisms and FANCC protein functions: further insights into the role for oxidative stress in Fanconi's anaemia phenotype.
Pagano G
Carcinogenesis; 2000 May; 21(5):1067-8. PubMed ID: 10783335
[TBL] [Abstract][Full Text] [Related]
3. Development and characterization of immortalized fibroblastoid cell lines from an FA(C) mouse model.
Tomkins DJ; Care M; Carreau M; Buchwald M
Mutat Res; 1998 Jul; 408(1):27-35. PubMed ID: 9678061
[TBL] [Abstract][Full Text] [Related]
4. Fanconi's anemia--chromosome breakage studies in homozygotes and heterozygotes.
Rosendorff J; Bernstein R
Cancer Genet Cytogenet; 1988 Jul; 33(2):175-83. PubMed ID: 3133104
[TBL] [Abstract][Full Text] [Related]
5. [Molecular basis of Fanconi's anemia].
Digweed M
Klin Padiatr; 1999; 211(4):192-7. PubMed ID: 10472548
[TBL] [Abstract][Full Text] [Related]
6. Positional cloning of the Fanconi anaemia group A gene.
Fanconi anaemia/Breast cancer consortium
Nat Genet; 1996 Nov; 14(3):324-8. PubMed ID: 8896564
[TBL] [Abstract][Full Text] [Related]
7. Expression cloning of a cDNA for the major Fanconi anaemia gene, FAA.
Lo Ten Foe JR; Rooimans MA; Bosnoyan-Collins L; Alon N; Wijker M; Parker L; Lightfoot J; Carreau M; Callen DF; Savoia A; Cheng NC; van Berkel CG; Strunk MH; Gille JJ; Pals G; Kruyt FA; Pronk JC; Arwert F; Buchwald M; Joenje H
Nat Genet; 1996 Nov; 14(3):320-3. PubMed ID: 8896563
[TBL] [Abstract][Full Text] [Related]
8. Bone marrow failure in the Fanconi anemia group C mouse model after DNA damage.
Carreau M; Gan OI; Liu L; Doedens M; McKerlie C; Dick JE; Buchwald M
Blood; 1998 Apr; 91(8):2737-44. PubMed ID: 9531583
[TBL] [Abstract][Full Text] [Related]
9. A novel diagnostic screen for defects in the Fanconi anemia pathway.
Shimamura A; Montes de Oca R; Svenson JL; Haining N; Moreau LA; Nathan DG; D'Andrea AD
Blood; 2002 Dec; 100(13):4649-54. PubMed ID: 12393398
[TBL] [Abstract][Full Text] [Related]
10. Clinical variability of Fanconi anemia (type C) results from expression of an amino terminal truncated Fanconi anemia complementation group C polypeptide with partial activity.
Yamashita T; Wu N; Kupfer G; Corless C; Joenje H; Grompe M; D'Andrea AD
Blood; 1996 May; 87(10):4424-32. PubMed ID: 8639804
[TBL] [Abstract][Full Text] [Related]
11. Failure of diepoxybutane to enhance sister chromatid exchange levels in Fanconi's anemia patients and heterozygotes.
Porfirio B; Dallapiccola B; Mokini V; Alimena G; Gandini E
Hum Genet; 1983; 63(2):117-20. PubMed ID: 6840755
[TBL] [Abstract][Full Text] [Related]
12. [Progress of research on protein composition and gene therapy of Fanconi anaemia - review].
Li ZY; Zou YF; Deng YB
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Apr; 12(2):231-5. PubMed ID: 15157341
[TBL] [Abstract][Full Text] [Related]
13. Novel mutations and polymorphisms in the Fanconi anemia group C gene.
Gibson RA; Morgan NV; Goldstein LH; Pearson IC; Kesterton IP; Foot NJ; Jansen S; Havenga C; Pearson T; de Ravel TJ; Cohn RJ; Marques IM; Dokal I; Roberts I; Marsh J; Ball S; Milner RD; Llerena JC; Samochatova E; Mohan SP; Vasudevan P; Birjandi F; Hajianpour A; Murer-Orlando M; Mathew CG
Hum Mutat; 1996; 8(2):140-8. PubMed ID: 8844212
[TBL] [Abstract][Full Text] [Related]
14. The genetics of Fanconi's anaemia.
Dokal I
Baillieres Best Pract Res Clin Haematol; 2000 Sep; 13(3):407-25. PubMed ID: 11030042
[TBL] [Abstract][Full Text] [Related]
15. Assessment of mitomycin C sensitivity in Fanconi anemia complementation group C gene (Fac) knock-out mouse cells.
Otsuki T; Wang J; Demuth I; Digweed M; Liu JM
Int J Hematol; 1998 Apr; 67(3):243-8. PubMed ID: 9650445
[TBL] [Abstract][Full Text] [Related]
16. Fanconi's anemia: a cytogenetic study on lymphocyte and bone marrow cultures utilizing 1,2:3,4-diepoxybutane.
Marx MP; Smith S; Heyns AD; van Tonder IZ
Cancer Genet Cytogenet; 1983 May; 9(1):51-9. PubMed ID: 6839306
[TBL] [Abstract][Full Text] [Related]
17. Complementation group assignments in Fanconi anemia fibroblast cell lines from North America.
Jakobs PM; Fiddler-Odell E; Reifsteck C; Olson S; Moses RE; Grompe M
Somat Cell Mol Genet; 1997 Jan; 23(1):1-7. PubMed ID: 9217996
[TBL] [Abstract][Full Text] [Related]
18. A functionally active retrovirus vector for gene therapy in Fanconi anemia group C.
Walsh CE; Grompe M; Vanin E; Buchwald M; Young NS; Nienhuis AW; Liu JM
Blood; 1994 Jul; 84(2):453-9. PubMed ID: 7517716
[TBL] [Abstract][Full Text] [Related]
19. Phenotypic correction of Fanconi anemia in human hematopoietic cells with a recombinant adeno-associated virus vector.
Walsh CE; Nienhuis AW; Samulski RJ; Brown MG; Miller JL; Young NS; Liu JM
J Clin Invest; 1994 Oct; 94(4):1440-8. PubMed ID: 7929819
[TBL] [Abstract][Full Text] [Related]
20. Sequence variations in the Fanconi anaemia gene, FAC: pathogenicity of 1806insA and R548X and recognition of D195V as a polymorphic variant.
Lo ten Foe JR; Barel MT; Thuss P; Digweed M; Arwert F; Joenje H
Hum Genet; 1996 Nov; 98(5):522-3. PubMed ID: 8882868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
